News
ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...
4d
Health and Me on MSN'I Thought It Was Something I Ate', Woman Got Diagnosed With Stage 4 Ovarian Cancer After A Routine Ultrasound Revealed Terminal IllnessA Kolkata teacher beats Stage IV ovarian cancer with advanced surgery, genetic testing, and targeted therapy—while inspiring ...
The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.
A woman who was in the best shape of her life before being diagnosed with a 'rare' form of cancer has spoken out about her ...
GET IT CHECKED!!! If the doctor pooh-poohs it, get it checked by a different doctor. Ultimately, what you do is up to you, ...
Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...
As early-onset cancers rise, more people are faced with the question of how their treatment might affect their ability to ...
Germany has become one of the world’s leading destinations for advanced cancer care, offering cutting-edge therapies, ...
Fiona Phillips has revealed the 'humiliating' tests she was subjected to in hospital before being diagnosed with early-onset ...
Kate Middleton has sparked new fears for her health by skipping the annual Royal Ascot horse races, leaving her glum-looking ...
Peter Moulding joined a clinical trial for the drug AMP945 not really knowing whether it would help him with deadly stage four pancreatic cancer. Now he is in complete remission – one of only two ...
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in patients with platinum-sensitive ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results